Results 271 to 280 of about 34,346 (291)

Post-chikungunya hyperpigmentation

Postgraduate Medical Journal, 2020
A 43-year-old woman presented with facial hyperpigmentation for the past 1 week. She had been hospitalised a month back with high-grade fever, headache, severe arthralgia and generalised morbiliform rash; IgM antibody test for chikungunya virus by ELISA was found positive.
Abheek Sil, Surajit Kumar Biswas, Dibyendu Bikash Bhanja, Sisir Das, Avik Panigrahi   +4 more
openaire   +2 more sources

Fluorouracil-Induced Hyperpigmentation

New England Journal of Medicine, 2020
Fluorouracil-Induced Hyperpigmentation A 57-year-old man received FOLFOX (leucovorin, fluorouracil, and oxaliplatin) as treatment for colon cancer.
Jordan K. Schaefer, Nithya Ramnath
openaire   +2 more sources

Postinflammatory Hyperpigmentation

Dermatologic Clinics, 1988
The epidermis provides a barrier against environmental toxins. The epidermal inflammatory response (dermatitis) causes the release of many peptides, chemical agents that alter the activity of both immune cells and pigment cells. Postinflammatory pigmentation may be an indicator that the melanocytes are part of the epidermal inflammatory system ...
openaire   +2 more sources

Hereditary diffuse hyperpigmentation

Clinical and Experimental Dermatology, 1980
Summary A healthy white female of normal intelligence aged 33 years, who presented with scalp hair thinning, showed congenital mottling of the skin more marked over the trunk and with epidermal atrophy on histology, smooth fingertips, brittle finger nails some split at the free end, and warty palmar keratoses. She gave a history of frictional blisters
openaire   +2 more sources

Innovations in Hyperpigmentation

Dermatologic Clinics
Photoprotection remains the foundation of treatment for all dyschromias and cosmetic camouflage as it provides concealment of pigmentation until therapeutic agents are effective. Innovations in the treatment of dyschromias encompass topical, systemic, and procedural modalities.
Charissa N, Obeng-Nyarko, Kevin S, Puerta Durango, Shanelle, Jackson, Susan C, Taylor   +3 more
openaire   +2 more sources

Imipramine-Associated Hyperpigmentation

Annals of Pharmacotherapy, 2003
OBJECTIVE: To inform clinicians of the potential for severe and persistent facial hyperpigmentation with the long-term use of imipramine. CASE SUMMARY: A 65-year-old white male veteran with a history of paranoid schizophrenia was referred to the psychiatry service by a dentist who thought that the patient was both cyanotic and psychotic.
Charles E, Dean, Frank M, Grund
openaire   +2 more sources

Treatment of Hyperpigmentation

Facial Plastic Surgery Clinics of North America, 2011
Disorders of hyperpigmentation encompass a plethora of pigmentary problems that can range from inherited to acquired. This article focuses on two prevalent disorders of hyperpigmentation and their treatment: melasma and postinflammatory hyperpigmentation.
Anthony M, Rossi, Maritza I, Perez
openaire   +2 more sources

DISORDERS OF HYPERPIGMENTATION

Dermatologic Clinics, 2000
Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement.
A G, Pandya, I L, Guevara
openaire   +2 more sources

Hyperpigmentation

Clinical Pediatrics, 2007
Elias, Tessema, Nedim, Cakan, Deepak, Kamat   +2 more
openaire   +2 more sources

Serpentine Supravenous Hyperpigmentation

New England Journal of Medicine, 2022
Nadine S. Maalouf, Meggie Morand
openaire   +2 more sources